Healthcare AI News 8/28/24 – HIStalk
News
Medscape launches a free AI scribe for US physicians that can summarize a patient visit in SOAP, H&P, or POMR format.
Researchers find that about only about half of the 500 AI-powered medical devices…
News
Medscape launches a free AI scribe for US physicians that can summarize a patient visit in SOAP, H&P, or POMR format.
Researchers find that about only about half of the 500 AI-powered medical devices…
Introduction
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, primarily due to the challenges in early detection and monitoring. However, the recent advancements in artificial intelligence (AI) are revolutionizing lung cancer…
What You Should Know:
– Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN), a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through…
Continue ReadingWhat You Should Know:
– Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant.
– The new AI solution is now…
Continue Reading“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.”
Those remarks came from Ajay Shah, CEO of San Francisco-based…
Continue ReadingWhat You Should Know:
– AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA 510(k) clearance for its groundbreaking CARDIO software platform.
– AISAP CARDIO…
Continue ReadingWhat You Should Know:
– OneStep, an innovator in digital healthcare, today announced its official integration with Epic’s Electronic Health Record (EHR) system.
– Now available on Epic’s App Marketplace, this integration is compatible with Fast Healthcare…
Continue ReadingWhat You Should Know:
– GrayMatters Health (GMH), developer of non-invasive treatments based on proprietary brain biomarkers associated with mental health disorders, today announced it is expanding its U.S. footprint with additional clinics now offering…
Continue ReadingWhen the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for…
Continue ReadingSome of the world’s most impactful companies were founded by college-aged visionaries — think Facebook, Microsoft and Dell. While it is unlikely that Brooklyn-based Cresilon will achieve levels of size and influence as grand…
Continue Reading